Cronos GroupCRON
About: Cronos Group, headquartered in Toronto, Canada, cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis primarily to Israel. In the US, the company has an option to acquire 5.9% of US multistate operator PharmaCann on a fully diluted basis upon easing of federal prohibition.
Employees: 356
Fund manager confidence
Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)
82% more call options, than puts
Call options by funds: $9.65M | Put options by funds: $5.31M
0.48% less ownership
Funds ownership: 11.37% [Q2] → 10.89% (-0.48%) [Q3]
2% less funds holding
Funds holding: 178 [Q2] → 175 (-3) [Q3]
10% less capital invested
Capital invested by funds: $101M [Q2] → $91.2M (-$9.96M) [Q3]
11% less first-time investments, than exits
New positions opened: 25 | Existing positions closed: 28
24% less repeat investments, than reductions
Existing positions increased: 35 | Existing positions reduced: 46
Research analyst outlook
We haven’t received any recent analyst ratings for CRON.
Financial journalist opinion
